Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40.7Revenue $M16.0Net Margin (%)-60.2Z-Score-1.1
Enterprise Value $M30.0EPS $-0.4Operating Margin %-62.7F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-62.7Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %-13.8Quick Ratio2.7Cash flow > EarningsN
Price/Sales1.75-y EBITDA Growth Rate %-1.2Current Ratio3.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-24.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-30.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.3ROI % (ttm)-16.6Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$1.2 - $2.13
($1.73)
$ 1.03-40%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $1.91 - $2.47
($2.2)
$ 1.03-53%New holding, 20000 sh.20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rhein Denis MichaelDirector 2014-12-01Sell0$0view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy22,500$2.3-55.22view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy100$2.44-57.79view
ENGLE J MELVILLECEO 2009-09-25Buy25,000$2.28-54.82view
MCENANY PATRICK JDirector 2009-05-19Buy6,250$2.32-55.6view
ENGLE J MELVILLECEO 2009-05-12Buy25,000$2.2-53.18view
MCENANY PATRICK JDirector 2009-05-08Buy6,250$2.12-51.42view
HUCKEL HUBERT E MDDirector 2007-11-16Buy36,500$7.8-86.79view
SEGAL DANIELVP Sales & Marketing 2007-03-01Buy750$12.56-91.8view
BARRY GEORGE JDirector 2006-05-12Buy250$16.28-93.67view

Press Releases about KOOL :

    Quarterly/Annual Reports about KOOL:

    News about KOOL:

    Articles On GuruFocus.com
    comment on KOOL Dec 01 2011 
    comment on KOOL Aug 26 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 

    More From Other Websites
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Other Events Dec 11 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 05 2014
    Cesca Therapeutics Appoints Mr. Denis Michael Rhein to Its Board of Directors Dec 05 2014
    Cesca Therapeutics Invited to Present at LD Micro Conference and the World Stem Cell Summit Nov 26 2014
    Cesca Therapeutics Announces Filing of U.S. Pivotal IDE Application for No-Option Critical Limb... Nov 24 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 21 2014
    CESCA THERAPEUTICS INC. Financials Nov 21 2014
    Cesca Therapeutics Announces Filing of U.S. Pivotal IDE Application for No-Option Critical Limb... Nov 20 2014
    10-Q for Cesca Therapeutics, Inc. Nov 18 2014
    CESCA THERAPEUTICS REPORTS FIRST QUARTER FISCAL 2015 RESULTS Nov 14 2014
    CESCA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report Nov 14 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 13 2014
    Cesca Therapeutics Reports First Quarter Fiscal 2015 Results Nov 13 2014
    Cesca Therapeutics to Announce First Quarter Fiscal 2015 Results on November 13, 2014 Nov 12 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 03 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Oct 30 2014
    Cesca Therapeutics Announces Change in Executive Leadership Oct 29 2014
    Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank Oct 13 2014
    Cesca Therapeutics to Present at Stem Cell Meeting on the Mesa Oct 06 2014
    10-K for Cesca Therapeutics, Inc. Oct 01 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK